Breast Cancer: Later Stage Treatment
SHARE

Breast Cancer: Later Stage Treatment

Treatment for advanced breast cancer can vary greatly depending on the specific features of the disease. Here, you'll find important information about those features and treatment options.

Later Stage Treatment: Understanding The Options

SEE MORE   

To help you understand your diagnosis and treatment options, check out our simple guides:

Later Stage

What are the Treatment Options for Late-Stage Breast Cancer?

Dr. Elizabeth Comen
Memorial Sloan Kettering Cancer Center
Later Stage

When Breast Cancer Spreads to the Bones

Dr. Elizabeth Comen
Memorial Sloan Kettering Cancer Center
Later Stage

Metastatic Breast Cancer: You Are Not a Statistic

Later Stage Treatment: Understanding The Options

To help you understand your diagnosis and treatment options, check out our simple guides:

Later Stage Treatment: The Latest Developments

Overview

A Better Option For Women With Common Type Of Advanced Breast Cancer: New Trial Data Provides Hope

Dr. Rodrigo Leão Edelmuth
Hospital Israelita Albert Einstein
Later Stage

Three Things You Should Know About the ESR1 Mutation in Breast Cancer

Dr. Kaique Filardi
University of São Paulo
Later Stage

Adding Maintenance Drug Can Slow Disease Progression For Patients With HER2+ Metastatic Breast Cancer: The Promising HER2CLIMB-05 Trial

Dr. Kaique Filardi
University of São Paulo
Later Stage

The evERA Trial: A Promising Treatment Option For Patients With Estrogen Receptor-Positive (ER+), HER2-Negative (HER2-) Breast Cancer

Dr. Kaique Filardi
University of São Paulo
Later Stage

New FDA Approval Creates New Hope For 70% Of Advanced Breast Cancer Patients: The Drug Imlunestrant Turns Off Estrogen Effectively

Dr. Rodrigo Leão Edelmuth
Hospital Israelita Albert Einstein
Later Stage

A New Standard: Trial Shows Targeted Drug Enhertu More Effective Than Chemo in Patients With Metastatic HR+, HER2-low Breast Cancer

Dr. Douglas Swords
Later Stage

How to Treat Metastatic Breast Cancer: The Drug Trodelvy Shows a Promising Boost in Survival Rates

Dr. Rodrigo Leão Edelmuth
Hospital Israelita Albert Einstein
Overview

A Better Option For Women With Common Type Of Advanced Breast Cancer: New Trial Data Provides Hope

Dr. Rodrigo Leão Edelmuth
Hospital Israelita Albert Einstein
Later Stage

Three Things You Should Know About the ESR1 Mutation in Breast Cancer

Dr. Kaique Filardi
University of São Paulo
Later Stage

Adding Maintenance Drug Can Slow Disease Progression For Patients With HER2+ Metastatic Breast Cancer: The Promising HER2CLIMB-05 Trial

Dr. Kaique Filardi
University of São Paulo
Later Stage

The evERA Trial: A Promising Treatment Option For Patients With Estrogen Receptor-Positive (ER+), HER2-Negative (HER2-) Breast Cancer

Dr. Kaique Filardi
University of São Paulo
Later Stage

New FDA Approval Creates New Hope For 70% Of Advanced Breast Cancer Patients: The Drug Imlunestrant Turns Off Estrogen Effectively

Dr. Rodrigo Leão Edelmuth
Hospital Israelita Albert Einstein
Later Stage

A New Standard: Trial Shows Targeted Drug Enhertu More Effective Than Chemo in Patients With Metastatic HR+, HER2-low Breast Cancer

Dr. Douglas Swords
Later Stage

How to Treat Metastatic Breast Cancer: The Drug Trodelvy Shows a Promising Boost in Survival Rates

Dr. Rodrigo Leão Edelmuth
Hospital Israelita Albert Einstein

Later Stage Treatment: Advances In Metastatic ER+ Breast Cancer

Overview

Helping Some Breast Cancer Patients to Decide on Chemotherapy

Dr. Kaique Filardi
University of São Paulo
Later Stage

Experimental Drug Gedatolisib Shows Promise For Patients With Advanced Breast Cancer After Treatment Stops Working

Dr. Kaique Filardi
University of São Paulo
Overview

Helping Some Breast Cancer Patients to Decide on Chemotherapy

Dr. Kaique Filardi
University of São Paulo
Later Stage

Experimental Drug Gedatolisib Shows Promise For Patients With Advanced Breast Cancer After Treatment Stops Working

Dr. Kaique Filardi
University of São Paulo

HER2- & HER2 Low: A Change in Treatment Paradigm

SEE MORE   
  • Experts say HER2- metastatic breast cancer patients should go back to their doctors to see whether their cancer is actually HER2 Low
  • Some women previously classified as HER2- may now qualify for treatment with a new drug called Enhertu that can extend overall survival rates
Treatment

A 'New' Type Of Breast Cancer? Practice-Changing Results? New Study Says Yes, And Provides Hope For Patients With HER2 'Low' Breast Cancer

Dr. James Taylor
Northeast Georgia Physicians Group
Later Stage

Alert for Women With Breast Cancer: What the Amazing New Findings About Drug Enhertu Mean for You & What to Ask Your Doctor

Sydney Schaefer

HER2- & HER2 Low: A Change in Treatment Paradigm

  • Experts say HER2- metastatic breast cancer patients should go back to their doctors to see whether their cancer is actually HER2 Low
  • Some women previously classified as HER2- may now qualify for treatment with a new drug called Enhertu that can extend overall survival rates

How is HER2-Positive Breast Cancer Treated?

Treatment

Treatment for HER2-Positive Breast Cancer

Women who are diagnosed with HER2-positive breast cancer have high levels of the HER2 protein on the outside of their cancer cells. For patients with early-stage disease, meaning they have relatively small tumors and no lymph involvement, a number of HER2-directed therapies have dramatically changed the landscape. Thes... Read More

Dr. Elizabeth Comen Memorial Sloan Kettering Cancer Center

Later Stage Treatment: Hormone Receptor Positive Breast Cancer

SEE MORE   
Later Stage

Experimental Drug Gedatolisib Shows Promise For Patients With Advanced Breast Cancer After Treatment Stops Working

Dr. Kaique Filardi
University of São Paulo
Treatment

New Drug Combo Can Keep Advanced HER2-Positive Breast Cancer Under Control Longer: Understanding The Data

Dr. Rodrigo Leão Edelmuth
Hospital Israelita Albert Einstein
Overview

A Better Option For Women With Common Type Of Advanced Breast Cancer: New Trial Data Provides Hope

Dr. Rodrigo Leão Edelmuth
Hospital Israelita Albert Einstein
Later Stage

What Are CD4/CD6 Inhibitors? And How Can They Fight Advanced Breast Cancer?

Dr. Elizabeth Comen
Memorial Sloan Kettering Cancer Center

New Option: How The Drug Kisqali and Endocrine Therapy Work For For Hard-To-Treat Breast Cancers

Later Stage

The FDA Just Approved a Promising New Drug for Metastatic Breast Cancer

Caroline Hopkins
SurvivorNet
Later Stage

Treating Metastatic Hormone Receptor-Positive Breast Cancer

Dr. Erica Mayer
Dana-Farber Cancer Institute
Later Stage

Hormone Therapies for Breast Cancer: CDK 4/6 Inhibitors

Dr. Erica Mayer
Dana-Farber Cancer Institute
Later Stage

CDK4/6 Inhibitors for Breast Cancer Explained

Dr. Rodrigo Leão Edelmuth
Hospital Israelita Albert Einstein
Later Stage

CD4/CD6 Inhibitors For Metastatic Breast Cancer -- What Are The Side Effects?

Dr. Elizabeth Comen
Memorial Sloan Kettering Cancer Center
Later Stage

Hormone Therapies for Breast Cancer: mTOR Inhibitors

Dr. Erica Mayer
Dana-Farber Cancer Institute
Later Stage

New Breast Cancer Drug Combination Shows Promising Results

Caroline Hopkins
SurvivorNet

Later Stage Treatment: Hormone Receptor Positive Breast Cancer

Later Stage Treatment: Triple Negative Breast Cancer

SEE MORE   
Later Stage

A New Treatment Combination Shows Promise For Hard-To-Treat Triple-Negative Breast Cancer — What New Data Means For Patients

Danielle Cinone
Later Stage

New Drug Extends Life in Most Aggressive Breast Cancer

Sonya Collins
Later Stage

Breast Cancer Breakthrough: Immunotherapy Shows Major Boost in Survival Rates

Roger Sergel
SurvivorNet
Later Stage

Chemo Plus Immunotherapy for Metastatic Triple-Negative Breast Cancer

Dr. Elizabeth Comen
Memorial Sloan Kettering Cancer Center
Later Stage

What's Next for Breast Cancer and Immunotherapy?

Dr. Sylvia Adams
NYU Perlmutter Cancer Center
Later Stage

Immunotherapy and Triple Negative Breast Cancer

Dr. Heather McArthur
Cedars-Sinai Medical Center
Later Stage

PARP Inhibitors Provide New Promise for Certain Metastatic Breast Cancers

Dr. Heather McArthur
Cedars-Sinai Medical Center

Later Stage Treatment: Triple Negative Breast Cancer

The Promise of Immunotherapy

Later Stage

An Immunotherapy Breakthrough: The Judy Perkins Story

Judy Perkins is a name that will be in the medical text books. She is the first person to be declared free of metastatic breast cancer after a course of immunotherapy. That's a big deal. She is what's known in the world of clinical trials as an "exceptional responder." SurvivorNet went to meet Judy about a year ago at... Read More

Judy Perkins

Later Stage Treatment: Should I Consider Clinical Trials?

SEE MORE   
Treatment

Clinical Trials for Breast Cancer

Dr. Elizabeth Comen
Memorial Sloan Kettering Cancer Center

Why I'd Choose a Clinical Trial For Myself

Dr. Ben Neel
NYU Perlmutter Cancer Center
Treatment

When Should I Consider Clinical Trials?

Dr. Leena Gandhi
Dana-Farber Cancer Institute

Dr. Alana Welm

Huntsman Cancer Institute
Later Stage

Clinical Trials and What Statistics Really Mean

Dr. Scott Strome
University of Maryland
Treatment

The Father of Immunotherapy Recommends Multiple Opinions

Dr. Steven Rosenberg
National Cancer Institute

Later Stage Treatment: Should I Consider Clinical Trials?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider